Cannabis Science announces manufacturing is underway for scheduled October

Cannabis Science, Inc., a pioneering US biotech company developing pharmaceutical cannabis products, has announced that the manufacturing is underway for its upcoming release of the first Cannabis Science brand of products. The company expects to receive the first sample for market release testing in a few days. The company will then announce the formal release of the products through its designated suppliers.

The initial Cannabis extract-based products will be made available to licensed medical marijuana patients in Colorado. The company will then expand across the United Stated in each legal State with special appointed legal distributors in each State.

The first products will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. For example, Cannabis Science has frequently been contacted by cancer patients seeking extract-based formulations for topical or internal use. Cannabis Science is responding to these patient requests for quality products. In the very near future, Cannabis Science will announce details of availability.

In light of the accumulating anecdotal reports of the successful cancer treatments with cannabis extracts, the company will continue to keep patients updated on current peer-reviewed scientific literature supporting the historical and modern use of cannabis to treat "tumours”. Unlike conventional methods, cannabis medicines have an outstanding safety profile allowing patients in states with medical marijuana laws to safely make informed decisions to legally self-administration of various cannabis-based preparations.

Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products.